The FDA has approved Gilead's Epclusa (sofosbuvir+velpatasvir) for hepatitis C, the first interferon-free combination treatment for all six major forms of the virus. The drug represented the next ...

Abstract: Fabrics present significant challenges to robotic manipulation due to their complex dynamics and infinite degrees of freedom. This letter proposes a non-prehensile approach to aligning a ...